Form 4: Arteris CFO Sells Shares Under Pre-Arranged Trading Plan

Arteris, Inc.'s VP and Chief Financial Officer, Nicholas B. Hawkins, sold 5,638 shares of common stock for approximately $10.50 per share under a Rule 10b5-1 trading plan.

Summary

• Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc. (AIP), sold 5,638 shares of the company's common stock.
• The transaction occurred on July 29, 2025.
• The shares were sold at a weighted average price of $10.5013, with individual sales ranging from $10.50 to $10.52.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Hawkins on May 20, 2024.
• Following this transaction, Mr. Hawkins directly beneficially owns 124,910 shares of Arteris, Inc. common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral because the sale was executed under a pre-arranged 10b5-1 trading plan, which is a common and often expected practice for executives to manage their personal finances and equity holdings. It does not necessarily indicate a negative outlook on the company's future.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned disposition rather than a reaction to new, non-public information.

Negatives

• An insider sale, even under a 10b5-1 plan, can be perceived negatively as it reduces the officer's direct stake in the company.
• The sale of 5,638 shares represents a reduction in the CFO's direct beneficial ownership.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This insider transaction is a routine disclosure for publicly traded companies and does not inherently reflect broader industry trends. It is specific to the individual's financial planning and compensation structure within Arteris, Inc.

Stakeholder Impact

• Shareholders: The sale slightly reduces the CFO's direct ownership, which could be interpreted by some as a minor reduction in alignment, though mitigated by the 10b5-1 plan.

Key Dates

Recommendation

The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 plan. This type of transaction is generally not indicative of new material information about the company's performance or outlook. Therefore, it does not provide a basis for a change in investment recommendation, suggesting a 'hold' position for existing investors who should rely on broader company fundamentals and market conditions.

Keywords

Arteris Inc., AIP, Nicholas B. Hawkins, CFO, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Executive Compensation, Share Disposition